Help your TREMFYATM patients
get started quickly with a trial
at no cost. Send in one simple
form to Janssen CarePath to
enroll your patient.
At the conclusion of the trial
program, you and the patient
can decide if it is clinically
appropriate to continue
Eligible commercially insured
patients pay just $5* per injection
with the Janssen CarePath
When coverage is delayed (>5 days)
or denied, commercially insured
patients may be eligible to receive
TREMFYATM at no cost.
Medicare patients are eligible for the PsO Simple Trial Program; however, there is no guarantee for continuous accessibility at the end of the program.
*Up to a maximum of $20,000 program benefit per calendar year. Not valid for patients enrolled in Medicare, Medicare Part D, Medicaid, or other federally funded programs.